© Reuters.
DiaSorin S.p.A. (DIA.MI), a global leader in the field of in vitro diagnostics, presented its full-year 2023 earnings report, revealing a year of strategic progress and financial performance marked by both challenges and optimism. CEO Carlo Rosa highlighted the successful integration of Luminex (NASDAQ:), the approval of the LIAISON Plex instrument and respiratory panel,…
